The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

Bexobrutideg, a first-in-class Bruton’s tyrosine kinase degrader, has been granted orphan drug designation from the FDA in ...

The study, published in The Lancet Haematology, has revealed that the injection had a 73% response rate among Indian patients ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Apart from breathing issues like breathlessness and pain in the chest, signs and symptoms of lung cancer extend way beyond, ...

BioVaxys common shares are listed on the Canadian Securities Exchange under the stock symbol "BIOV" and trade on the Frankfurt Bourse (FRA: 5LB) and in the U.S. on the OTC Markets (OTCQB marketplace).

Recursion Pharma RXRX shares have plunged 37.1% in the past month compared with the industry’s 1.4% decline. The company has also underperformed in the sector and the S&P 500 during the same time ...

Equities research analysts at Roth Capital issued their FY2029 earnings per share estimates for Cellectar Biosciences in a ...

Napa photographer Bob McClenahan captured evocative images of Napa Valley, people, places and happenings. He died on March 7 ...